Newport Laboratories

What Newport Laboratories does

Newport Laboratories is a U.S. veterinary biologics manufacturer that develops and produces autogenous (custom-made) whole-cell vaccines for food animals, operating as the autogenous-vaccines brand under parent company Vaxxinova. The company is headquartered in Worthington, Minnesota, with a second production facility in Willmar, Minnesota, and sells directly to veterinarians and food animal producers across the United States.

The company's product architecture rests on two technical pillars: (i) its proprietary Siderophore Receptors and Porins (SRP) platform, a patented mechanism that induces host antibodies against conserved bacterial cell-wall components responsible for iron transport, effectively starving target bacteria of an essential nutrient, and (ii) proprietary whole-cell autogenous biologics manufacturing using adjuvants described as exclusive to Vaxxinova. The branded VAXXON SRP vaccine line spans poultry (E. coli, Salmonella Enteritidis, Pasteurella, EDS, and Metapneumovirus/SHS), bovine (Salmonella, Klebsiella, E. coli O157, Salmonella Dublin, plus the Bio One sub-brand), and swine (reproductive, multi-systemic, gut-health, and respiratory categories). Alongside licensed products, Newport offers custom-made autogenous vaccines developed in collaboration with attending veterinarians against pathogen isolates from specific herds and flocks.

Commercially, Newport runs a sales-led, direct-distribution model with no online transactional channel: customers contact the company via toll-free phone numbers per facility or email for quotes, and field veterinarians are positioned as the consultative entry point for autogenous vaccine selection, supported by a free swine diagnostic manual. The most material recent commercial event is a 2025 USDA approval allowing the first-ever import of a live vaccine (aMPV) into the United States, followed by the launch of the VAXXON SHS live and killed vaccine for the U.S. poultry market — a regulatory and product move that materially extends the company's addressable product surface in poultry respiratory disease.

Name

Newport Laboratories

Legal name

Newport Laboratories

Website

https://newportlabs.com

Company type

Private

Founded year

1994

Operating status

Operating

Headcount range

11–50 employees

Short description

Newport Laboratories is a U.S. veterinary biologics manufacturer operating as a Vaxxinova subsidiary, producing custom autogenous whole-cell vaccines and patented SRP-technology vaccines for poultry, bovine, and swine across two Minnesota facilities.

Ownership category

akta.pro rank

Product category

Veterinary Vaccines

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Veterinary Vaccines (Biologics) (HLAMAEAL)

akta.pro secondary industries

Autogenous (Herd-Specific) Vaccines (HLAMAKAF), Livestock Vaccines (Cattle, Swine, Sheep & Goats) (HLAMAKAB), Poultry Vaccines (HLAMAKAC), Vaccine Technology Platforms (Live, Inactivated, Subunit, Vector, mRNA/DNA) (HLAMAKAH), Vaccine R&D, Clinical/Field Trials & Regulatory Affairs (HLAMAKAM)

Keywords

• Veterinary vaccines
• Autogenous biologics
• Animal health biologics
• Poultry vaccines
• Livestock vaccines

Headquarters

HQ city

Worthington

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Technology or R&D, Supply Chain, Infrastructure, Marketing or Sales

Revenue model

1. Veterinary Vaccines Sales: Sale of licensed and autogenous bacterial vaccines for poultry, bovine, and swine. Vaccines are manufactured and sold directly to veterinarians and food animal producers.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Newport Laboratories develops and manufactures autogenous (custom-made) whole-cell veterinary vaccines for food animals (poultry, bovine, and swine) at its Minnesota facilities in Worthington and Willmar. The company also produces SRP-branded licensed vaccines using its patented Siderophore Receptors and Porins (SRP) technology, which starves bacteria of iron by inducing antibodies against conserved cell-wall components. Autogenous vaccines are manufactured in collaboration with attending veterinarians to address specific bacterial and viral pathogens on livestock operations.

Product overview

Vaxxinova is a veterinary biologics company that develops, manufactures, and sells vaccines for food animals. The company operates a platform-plus-products architecture featuring its proprietary SRP (Siderophore Receptors and Porins) Technology as the core platform, which is used across all SRP-branded vaccine products. Newport Laboratories serves as the primary autogenous/custom vaccines brand, while VAXXON SRP branded products represent the licensed vaccine line utilizing the patented SRP technology. The product portfolio spans three animal segments: Poultry (VAXXON SRP E. coli, VAXXON SRP E. coli-SE, VAXXON SRP SE, VAXXON SRP Pasteurella, VAXXON EDS, VAXXON SHS/Metapneumovirus, plus custom vaccines), Bovine (Bovine Autogenous, VAXXON SRP Salmonella, VAXXON SRP Klebsiella, VAXXON SRP E-coli O157, Salmonella Dublin SRP, and Bio One sub-brand), and Swine (Reproductive, Multi-systemic, Gut Health, Respiratory Diseases, plus custom vaccines and diagnostics support). All vaccines are manufactured at Minnesota facilities in Worthington and Willmar.

Differentiator

Problem solved

Functional benefit

Brands

• Newport Laboratories: Whole-cell autogenous biologics brand for veterinary vaccines

Products and services

• VAXXON SRP E. COLI Licensed SRP-based bacterial vaccine for poultry targeting E. coli, used by poultry producers and veterinarians for avian disease prevention.
• VAXXON SRP E. COLI-SE Licensed SRP-based vaccine for poultry addressing both E. coli and Salmonella Enteritidis, used by poultry producers and veterinarians.
• VAXXON SRP SE Licensed SRP-based vaccine for poultry targeting Salmonella Enteritidis, used by poultry producers and veterinarians.
• VAXXON SRP PASTEURELLA Licensed SRP-based bacterial vaccine for poultry targeting Pasteurella, used by poultry producers and veterinarians.
• VAXXON EDS Licensed vaccine for Egg Drop Syndrome (EDS) in poultry, used by poultry producers and veterinarians.
• VAXXON SHS (Metapneumovirus) Vaccine for Swollen Head Syndrome caused by Avian Metapneumovirus in poultry, available in both live and killed formulations, used by poultry producers and veterinarians.
• Poultry Custom (Autogenous) Vaccines Custom-made autogenous whole-cell vaccines developed with attending veterinarians for poultry producers to address specific bacterial and viral pathogens not covered by licensed products.
• Bovine Autogenous Vaccines Custom-made whole-cell autogenous vaccines for cattle addressing bacterial and viral pathogens, developed in collaboration with attending veterinarians.
• VAXXON SRP SALMONELLA Licensed SRP-based vaccine for cattle targeting Salmonella, used by cattle producers and veterinarians.
• VAXXON SRP KLEBSIELLA Licensed SRP-based vaccine for cattle targeting Klebsiella, used by cattle producers and veterinarians.
• VAXXON SRP E-COLI 0157 Licensed SRP-based vaccine for cattle targeting E. coli O157, used by cattle producers and veterinarians for pathogen reduction programs.
• SALMONELLA DUBLIN SRP Licensed SRP-based vaccine for cattle targeting Salmonella Dublin, used by cattle producers and veterinarians.
• Bio One Proprietary branded vaccine for cattle manufactured at Newport Laboratories' Minnesota facilities, sold under the Bio One brand.
• Swine Reproductive Vaccines Vaccines for reproductive diseases in swine, used by swine producers and veterinarians.
• Swine Multi-Systemic Vaccines Vaccines for multi-systemic diseases in swine, used by swine producers and veterinarians.
• Swine Gut Health Vaccines Vaccines addressing gut health issues in swine, used by swine producers and veterinarians.
• Swine Respiratory Disease Vaccines Vaccines for respiratory diseases in swine, used by swine producers and veterinarians.
• Swine Custom (Autogenous) Vaccines Custom-made autogenous vaccines for swine developed with attending veterinarians to address specific bacterial and viral pathogens on swine operations.

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators1 record

Recent moves5 records

Expansion highlights3 records

Direct peers

• Ceva Santé Animale: French veterinary biologics company with strong poultry and swine vaccine portfolios and global autogenous manufacturing capabilities that compete head-to-head with Newport in food animal bacterial vaccines.
• Huvepharma: Bulgarian-based animal health company with significant poultry and swine vaccine offerings, including autogenous and bacterial vaccines, making it a direct competitor in Newport's core market.
• Hipra: Spanish veterinary pharmaceutical and biologics company specializing in poultry and swine vaccines with autogenous capabilities, comparable to Newport in product mix, scale, and European heritage.
• Cambridge Technologies: US-based autogenous veterinary vaccine manufacturer serving swine, bovine, and poultry producers; competes directly with Newport in custom-made herd-specific biologics.

Broad incumbents

• Phibro Animal Health: Public animal health and nutrition company serving poultry, swine, and cattle producers with vaccines and health products that overlap Newport's customer base with a broader portfolio.
• Merck Animal Health: Major animal health division with poultry, swine, and bovine vaccine franchises including licensed and autogenous offerings that overlap directly with Newport's food animal vaccine focus.
• Zoetis: Largest global animal health company offering vaccines and therapeutics across poultry, swine, and cattle; competes broadly with Newport's portfolio but at much larger scale across multiple species and therapy categories.
• Boehringer Ingelheim Animal Health: Global animal health giant with poultry (including avian influenza), swine, and cattle vaccines that competes with Newport in all three primary segments as a diversified incumbent.
• Elanco Animal Health: Public animal health company with poultry, swine, and cattle vaccine and therapeutic offerings that compete across Newport's three primary segments as a diversified incumbent.

Others

• Vaxxinova: Parent company of Newport Laboratories and international veterinary biologics firm; not a market peer but provides the strategic and R&D context within which Newport operates.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/newport-labs

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Newport Laboratories